We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Respironics to Market New Nebulizer System

By HospiMedica staff writers
Posted on 20 Oct 2004
A new nebulizer system that offers improved pulmonary drug delivery efficiency and has the potential to reduce drug and personnel costs in the critical care setting will be marketed worldwide by Respironics, Inc. More...
(Murrysville, PA, USA) under a nonexclusive agreement with Aerogen, Inc. (Mountain View, CA, USA).

Respironics will market and distribute the nebulizer with its new and existing ventilator support systems. The nebulizer, called Aeroneb Pro, incorporates Aerogen's proprietary OnQ aerosol generator, designed to improve the delivery of drugs for respiratory disorders in a critical care setting. Respironics is a leading developer, manufacturer, and distributor of products and programs that serve global sleep and respiratory markets.

"We're pleased to be working with Respironics, a worldwide leader in the development and commercialization of respiratory products,” noted Dr. Jane Shaw, chairman and CEO of Aerogen. "This relationship will expand the market penetration of our Aeroneb Pro for aerosolized delivery of respiratory therapies in the critical care setting.”

Aerogen develops drug-device combination aerosol products based on its OnQ generator technology to improve treatment of respiratory disorders. The company has reported the results of a phase 2 clinical study evaluating delivery of aerosolized amikacin for the treatment of ventilator-associated pneumonia. Additional drugs targeting improved respiratory therapy are in the feasibility and preclinical stages of development.





Related Links:
Respironics
Aerogen

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Immobilization System
Cranial 4Pi Immobilization
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.